Abstract

Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms

Author(s): Bramwell Bethany L

Issue: Nov/Dec 2009 - Geriatric Compounding

Page(s): 498-505

Download in electronic PDF format for $75
  • Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms Page 1
  • Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms Page 2
  • Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms Page 3
  • Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms Page 4
  • Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms Page 5
  • Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms Page 6
  • Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms Page 7
  • Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms Page 8

Abstract

Dysphagia in elderly patients significantly impacts nutrition, pharmacotherapy, and quality of life. Dysphagic patients, especially those with contributing degenerative neurological disorders, present unique challenges to their families, caregivers, and healthcare professionals. Pharmacists have a key role in proactively inquiring about dysphagia, ensuring safety, increasing compliance, and ultimately improving clinical outcomes through medication regimen assessment in this rapidly growing patient population.

Related Keywords

  • aging
  • swallowing disorders
  • dysphagia
  • degenerative neurological disorders
  • alternative dosage forms
  • thickened fluids
  • thickeners
  • disintegrating tablets
  • transdermal delivery
  • topical preparations
  • formulations

Related Categories

  • EAR NOSE THROAT
  • EXCIPIENTS
  • FORMULATIONS
  • GERIATRICS
  • NUTRITION AND NUTRICEUTICALS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2009
Pg. 498-505
Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms
Author(s): Bramwell Bethany L
Nov/Dec 2022
Pg. 516-521
Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Author(s): Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
Mar/Apr 2007
Pg. 145-148
Quality Control Analytical Methods: Considerations in Compounding Peroral Solid Dosage Forms
Author(s): Vu Nicole
May/Jun 2002
Pg. 178-179
Lollipops: The Evolution of a Dosage Form
Author(s): Mason Dave, Fields Shannon
Sep/Oct 2003
Pg. 386-388
Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder
Author(s): Gupta Vishnu D
Jul/Aug 2008
Pg. 372-374
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms
Author(s): Gupta Vishnu D
Jan/Feb 2009
Pg. 14-18
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Author(s): Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
Jul/Aug 2013
Pg. 312-322
Basics of Compounding: Foam Dosage Forms
Author(s): Allen Loyd V Jr
Nov/Dec 2014
Pg. 479-484
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms
Author(s): Akers Michael J
Jan/Feb 2023
Pg. 24-29
Basics: A Review: In Situ Gel Dosage Forms for Herbal Medicine Delivery
Author(s): Rachmawati Putriana
Sep/Oct 2022
Pg. 356
PreScription: A New Dosage Form
Author(s): Allen Loyd V Jr
Jan/Feb 2017
Pg. 47-56
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Author(s): Akers Michael J
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Nov/Dec 2001
Pg. 480-481
Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets
Author(s): Gupta Vishnu D
Mar/Apr 2016
Pg. 164-166
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures
Author(s): Nahata Milap C
Sep/Oct 2022
Pg. 370-377
Recent Formulation Advances and Preparation of Orally Disintegrating Tablets
Author(s): Ejeta Fikadu
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Jan/Feb 2010
Pg. 32-38
Unit Dose Packaging and Repackaging of Solid and Liquid Dosage Forms in an Institutional Setting
Author(s): McElhiney Linda F